Showing results (11-20 of 366) with videos related to
Sort By:
Pageof 37
Trends in Molecular Medicine|April 27, 2004
Altered states: selectively drugging the Hsp90 cancer chaperonePaul WorkmanCurrent Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
Strategies for treating cancers caused by multiple genome abnormalities: from concepts to cures?Paul WorkmanCancer Chemotherapy and Pharmacology|June 24, 2003
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperonesPaul WorkmanCancer Research|October 2, 2023
The NCI-60 Human Tumor Cell Line Screen: A Catalyst for Progressive Evolution of Models for Discovery and Development of Cancer DrugsPaul WorkmanAdvances in Experimental Medicine and Biology|September 23, 2020
Correction to: Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal PerspectivePaul WorkmanInternational Journal of Clinical Pharmacy|December 23, 2018
Hassles with medication management perceived by caregivers of adults who have intellectual or developmental disabilitiesSteven R Erickson, Yanmen YangJournal of the American Pharmacists Association : Japha|January 24, 2015
Health literacy and medication administration performance by caregivers of adults with developmental disabilitiesSteven R Erickson, Barbara LeRoyCurrent Medical Research and Opinion|February 11, 2005
Variation in the distribution of patient-reported outcomes based on different definitions of defining asthma severitySteven R Erickson, Duane M KirkingInternational Journal of Sport Nutrition and Exercise Metabolism|September 1, 2015
Masters Swimmers Use More Dietary Supplements Than a Large National Comparison Population in the United StatesSally K Guthrie, Steven R EricksonAdvances in Cancer Research|July 25, 2006
Inhibitors of the HSP90 molecular chaperone: current statusSwee Sharp, Paul WorkmanPageof 37